Soligenix, inc. (SNGX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Contract revenue

3,421

3,215

3,403

3,521

3,827

3,965

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant revenue

988

1,414

1,555

1,564

1,438

1,275

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

9,148

10,448

11,722

12,637

10,559

8,641

7,460

5,781

5,591

5,545

4,318

2,123

1,231

565

0

0

0

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

127

261

848

1,357

1,497

2,176

1,896

2,002

2,658

2,647

3,266

3,397

3,144

2,995

2,859

2,502

2,662

2,870

0

0

0

-

Total revenues

4,409

4,629

4,959

5,085

5,266

5,241

5,515

5,955

5,221

5,432

0

0

0

-

0

-

-

8,768

7,722

6,630

6,948

7,043

6,495

4,020

3,234

3,224

0

0

0

-

-

-

-

-

0

-

-

0

0

Cost of revenues

3,468

3,567

3,868

4,139

4,546

4,597

4,781

5,018

4,201

4,310

4,467

5,623

7,288

8,433

9,692

10,112

8,587

6,882

5,935

4,994

5,212

5,313

4,799

2,936

2,429

2,544

2,176

2,691

2,780

2,593

2,484

2,377

2,110

2,108

2,338

2,032

0

0

0

Gross profit

940

1,062

1,091

946

719

643

733

937

1,019

1,122

1,375

1,356

1,860

2,015

2,030

2,530

1,995

1,886

1,786

1,635

1,736

1,729

1,695

1,084

804

679

471

575

617

551

510

5,481

5,391

5,554

5,532

486

0

0

0

Operating expenses:
Research and development

9,180

8,122

8,145

7,273

6,590

6,750

6,268

5,479

6,092

5,507

4,469

5,040

4,084

4,295

5,101

5,183

5,798

5,399

1,485

5,315

5,085

5,086

8,290

4,417

5,345

5,071

4,973

4,128

2,489

2,609

2,792

4,763

5,776

6,272

6,505

5,233

0

0

0

Research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

3,475

3,480

3,334

3,212

3,094

2,951

2,936

2,980

3,176

3,209

3,225

3,164

3,317

3,428

3,591

3,779

3,655

3,596

3,498

3,389

3,380

3,403

3,284

3,264

3,118

2,765

2,710

2,558

2,465

2,632

2,408

2,445

2,293

2,242

2,217

2,166

0

0

0

Research and development expense - milestone

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation  research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Stock-based compensation  general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total operating expenses

17,655

11,603

11,479

10,486

9,684

9,702

9,205

8,459

9,269

8,716

7,694

8,205

7,402

7,724

8,692

8,963

9,453

8,996

8,983

12,704

12,466

12,490

11,574

7,682

8,463

7,836

7,684

6,686

4,954

5,242

5,201

7,208

8,069

8,514

8,722

7,461

0

0

0

Loss from operations

-16,714

-10,541

-10,388

-9,540

-8,964

-9,058

-8,471

-7,522

-8,249

-7,593

-6,319

-6,848

-5,542

-5,709

-6,662

-6,432

-7,457

-7,110

-7,196

-11,068

-10,729

-10,761

-9,879

-6,598

-7,658

-7,156

-7,212

-6,111

-4,337

-4,690

-4,690

-1,727

-2,678

-2,960

-3,190

-6,974

0

0

0

Other income:
Foreign currency transaction (loss)/gain

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,541

-814

-5,038

-2,569

1,201

-2,732

523

-2,166

-3,436

4,903

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

29

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11

-12

-8

-2

1

1

1

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

6

7

7

7

7

10

11

0

0

0

Research and development incentives

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-649

0

-

0

0

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other income, net

-

-

0

0

-

-

0

0

0

-

-

-

-

1,934

1,199

5,417

2,557

-1,209

0

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

Net loss before income taxes

-16,134

-9,966

-10,199

-9,340

-8,773

-8,899

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-836

-610

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-15,297

-9,355

-9,588

-8,729

-8,162

-8,899

-7,934

-7,035

-7,790

-7,147

-5,338

-6,048

-3,829

-3,245

-4,973

-526

-4,411

-7,831

-3,849

-10,973

-7,944

-6,706

-7,636

-9,846

-12,303

-10,058

-12,037

-6,236

-3,811

-4,163

0

0

0

-

-

-

-

-

-

Basic net loss per share

-

-

-

-

-

-

-

-

-

-

-0.17

-0.41

-0.32

-0.04

-0.49

-0.03

-0.37

-2.31

1.05

-1.55

-0.19

-

-0.21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-0.17

-0.41

-0.32

-0.07

-0.49

-0.19

-0.59

-0.81

-0.45

-1.55

-0.19

-

-0.21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic weighted average common shares outstanding

-

-

-

-

-

-

-

-

-

-

5,757

5,601

5,472

4,188

3,432

3,176

3,127

-19,200

2,648

2,572

24,405

-

20,671

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted weighted average common shares outstanding

-

-

-

-

-

-

-

-

-

-

5,757

5,601

5,472

4,368

3,432

3,273

3,260

-19,381

2,829

2,572

24,405

-

20,671

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,180

-6,962

0

0

0

Basic and diluted net loss per share

-0.32

-0.13

-0.14

-0.12

-0.09

-0.12

-0.11

-0.18

-0.27

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.05

-0.17

-

-

-0.28

-0.10

-0.08

-0.07

-0.09

-0.13

-0.08

0.20

-0.18

-0.16

-0.01

-0.01

Basic and diluted weighted average common shares outstanding

23,404

20,895

20,094

18,436

18,078

17,740

17,495

8,742

8,734

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,949

19,739

-

-

12,259

11,180

11,163

11,138

11,124

11,119

-

11,013

10,899

-

-

-

Basic and diluted weighted average common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,842

215,869

190,751